Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients Luis Escribano,

Slides:

Advertisements

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms Iván Álvarez-Twose,

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis Eveline van der Veer, PhD, Suzanne Arends, PhD, Sjoukje van der.

Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in.

Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations Sigurd Broesby-Olsen, MD, Thomas Kielsgaard Kristensen,

Clarification concerning amoxicillin skin testing

Cristina Teodosio, MSc, Andrés C

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect- induced anaphylaxis shows unique features versus other indolent SM

Fatty acids, inflammation, and asthma

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Atopic dermatitis: Age and race do matter!

Is 9 more than 2 also in allergic airway inflammation?

Desensitization to Chemotherapeutic Agents

Fatty acids, inflammation, and asthma

Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012 Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Rising prevalence of asthma is sex-specific in a US farming population

Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis Luis Escribano, MD, PhD, Andrés Garcı́a-Montero,

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect- induced anaphylaxis shows unique features versus other indolent SM

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Is there any role for allergen avoidance in the primary prevention of childhood asthma? Onno C.P. van Schayck, PhD, Tanja Maas, MSc, Janneke Kaper, PhD,

The National Biome Initiative: An allergy perspective

Nonadherence to Asthma Treatment: Getting Unstuck

Etiology of asthma exacerbations

An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1– related disease in children Kumud K. Singh, PhD, Alexis Lieser, MD,

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind,

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2 Phillip Lieberman, MD The Journal of Allergy.

Serum tryptase levels in atopic and nonatopic children

Impact of somatic and germline mutations on the outcome of systemic mastocytosis by Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason.

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis Eveline van der Veer, PhD, Suzanne Arends, PhD, Sjoukje van der.

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Christian Hennig, MD, Christine Happle, MD, Gesine Hansen, MD

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Genetic basis of the latex-fruit syndrome: Association with HLA class II alleles in a Spanish population Carlos Blanco, MD, PhD, Florentino Sánchez-García,

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms Iván Álvarez-Twose,

What is an “eosinophilic phenotype” of asthma?

Medication use in children with asthma in Finland from 1995 to 2006

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Diagnosis and management of early asthma in preschool-aged children

Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in.

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

Corinne A. Keet, MD, MS, Wayne G. Shreffler, MD, PhD, Roger D

Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature Can N. Kocabas, MD, Akif.

Distribution of subsets of blood monocytic cells throughout life

Benjamin Chaigne, MD, Hervé Watier, MD, PhD

Anaphylaxis Journal of Allergy and Clinical Immunology

KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis Sigurd Broesby-Olsen, MD, Thomas Kristensen,

Measles and immunomodulation

Guus A. Westerhof, MD, Elise M. Vollema, MD, Els J

Macrolide antibiotics and asthma treatment

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

Asthma: The past, future, environment, and costs

Environmental factors and eosinophilic esophagitis

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

Advances in pediatric asthma in 2007

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Natural history of cow’s milk allergy

Primary prevention of asthma and allergy

Presentation transcript:

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients Luis Escribano, MD, PhD, Iván Álvarez-Twose, MD, Laura Sánchez-Muñoz, MD, PhD, Andres Garcia-Montero, PhD, Rosa Núñez, MD, Julia Almeida, MD PhD, Maria Jara-Acevedo, MSc, Cristina Teodósio, MSc, Mónica García-Cosío, MD, PhD, Carmen Bellas, MD, PhD, Alberto Orfao, MD, PhD Journal of Allergy and Clinical Immunology Volume 124, Issue 3, Pages 514-521 (September 2009) DOI: 10.1016/j.jaci.2009.05.003 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Progression-free survival (PFS) and overall survival (OS) in mastocytosis (n = 145). Panels A-C show PFS according to β2-microglobulin serum levels ( normal vs increased) and presence () vs absence () of D816V KIT-mutation in all hematopoietic lineages, respectively. Panels D-G show OS according to presence () vs absence () of an AHNMD, increased () vs normal () serum alkaline phosphatase and age at diagnosis >60 years () vs <60 years (), respectively. Journal of Allergy and Clinical Immunology 2009 124, 514-521DOI: (10.1016/j.jaci.2009.05.003) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions